Business news with perspective

Priyanka Singh’s promotion to EVP, Operations & CFO signals Litera’s strategy to fuse operational might with its ambitious AI goals in a competitive market.

French firms Clean Cells and Naobios eye South Korea's booming biopharma sector, offering a rare integrated solution for viral vaccine and therapy development.

A new free, open-source tool from DEUTLI lets professionals extract AI image data 100% offline, solving a critical IP security risk for NDA-bound work.

Biotech firm Epitopea adds top expert Dr. Lisa Butterfield, validating its novel RNA vaccine approach targeting hidden cancer antigens for hard-to-treat tumors.

The food giant's $250M bond repurchase offer was nearly doubly oversubscribed, a strong market endorsement of its financial health and strategic debt management.

IVY Rx unveils its 2026 compounded GLP-1 program with clear pricing, but operates in a market facing intense FDA warnings and regulatory uncertainty.

The market for at-home NAD+ therapy is booming, but as telehealth offers new convenience, it faces a wave of regulatory and safety questions.

Replimune halts a promising cancer therapy and cuts jobs after a stunning FDA rejection, citing a 'failed' system and inconsistent regulatory process.

Allogene Therapeutics faces a make-or-break moment as it prepares to unveil crucial trial data for its 'off-the-shelf' cancer therapy, cema-cel.

Diamondback Energy is buying back nearly $1 billion in long-term debt. What does this strategic financial move reveal about its future and the energy sector?

Investors watch Gibson Energy closely as it prepares for its Q1 results amid mixed performance, strategic acquisitions, and a changing energy landscape.

Amid a complex economy, DPC Dash is rapidly expanding, breaking global sales records and winning millions with a unique digital and cultural strategy.

Stephan Crétier, who turned a $25k loan into a $14B security empire, will keynote at SWGSB, offering bankers crucial lessons in risk and resilience.

MOVA AtomForm's new Palette 300 uses 12 nozzles and AI to promise waste-free, high-speed multi-color printing. But can it deliver on its bold claims?

After a devastating crash left them with traumatic brain injuries, a NM couple secured a major settlement. Their story reveals the true cost of drunk driving.

Despite global jitters, luxury property in San Miguel de Allende and Querétaro is thriving. Discover why buyers are flocking to these Mexican hotspots.

Less than a year after its acquisition, Khoros launches Iris AI, an 'AI-native' platform aiming to unify customer engagement and unseat market leaders.

A jury found Abbott's Similac caused a fatal gut disease in premature infants, igniting a legal firestorm over what the formula giant knew and when.

A Chicago jury found Abbott liable for infants' injuries from Similac, adding to a wave of lawsuits over the deadly intestinal disease NEC.

Gensler's Andy Cohen joins the REIT's board, signaling a strategic shift toward design-led development in LA and Honolulu's premium real estate markets.